Clinical Trial Update: Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of combining Imprime PGG with Bevacizumab and Paclitaxel/Carboplatin in adults with untreated advanced non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Imprime PGG
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: HiberCell, Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED